Arcturus Therapeutics Holdings (ARCT)
(Delayed Data from NSDQ)
$20.55 USD
-0.46 (-2.19%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $20.56 +0.01 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Arcturus Therapeutics Holdings (ARCT) reported earnings of -$0.64 per share, beating the Zacks Consensus Estimate of $-1.85 per share. This reflects a positive earnings surprise of 65.41%. Look out for ARCT's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year decrease of 14.75%.
Earnings History
Price & Consensus
Zacks News for ARCT
New Strong Buy Stocks for September 13th
ARCT: What are Zacks experts saying now?
Zacks Private Portfolio Services